In vitro tissue models validated to mimic in vivo human physiology
to improve confidence in drug discovery
Models of the retinal neuro- and pigmented epithelium for use in modelling of retinopathies and safety studiesFind out more
Kidney Nephron Models
Used in combination or separately, our models of the glomerulus, proximal tubule and TAL give you an unprecedented ability to measure how your drug effects the kidneyFind out more
Lung Airway Models
A suite of models for studying fibrotic disease mechanisms in the lung enabling candidate screening and efficacy studiesFind out more
MPS Flow Models
Newcells has launched a new engineered micro-physiological system (MPS) flow technology compatible with our in vitro cell-based models.Find out more
Who we are
We are experts in building and applying complex models of human tissues for drug discovery.
We are cell biologists, tissue physiologists and assay development scientists focused on building models that balance complexity, functionality, throughput and efficiency to improve the predictive power of in vitro data.Find out more
What we do
We carry out in vitro studies or provide products that enable customers to generate data on efficacy, safety and transport to de-risk discovery and development.
Our experts collaborate with customers to design studies to provide data that answer critical questions for pre-clinical drug development. We run the study, provide and interpret the data, or we can supply products and support you in your in-house studies.Find out more
To improve the success of in vitro to clinical trials translation by developing and validating in vitro models for biomedical research.
We aim to contribute to the development of new innovative therapies by delivering services, products and tools based on our models of human tissues that provide data that informs and predicts how these therapies will behave in humans. Through the wider adoption of this approach, our work will advance the 3R’s policy in drug development.Find out more
Innovating to support drug discovery
How we work for our customers
Build human cell-based in vitro models
Apply our in-depth expertise to design the right study
Provide the data that answers key efficacy, safety or transport questions
Provide the tool or assay for customer in-house studies
Timely delivery of data to fit with customers deadlines
Newcells mission is to de-risk the decision-making process in drug development by providing physiologically relevant in vitro models that most accurately predict in vivo outcomes.
Globally recognised scientific expertise in cell physiology and organoid technology is embedded in all products & services. We engineer in vitro models from primary tissues and iPSCs to accelerate drug discovery and improve clinical translation.About us
An insight into R&D at Newcells Biotech with Dr Fiona Leslie, PhD, Lung platform scientist
Can you tell us a little bit about your professional journey and how you made the transition to industry? I have an undergraduate Degree in biomedical science and also completed…Read update
Mr Terry Pizzie joins Newcells Biotech Board as non-executive director
Terry’s career in the life science industry spans more than 30 years. He was the CEO of Cambridge based Horizon Discovery Plc, a public company listed on the UK…Read update
Follow us on social media: